Advertisement


Serum Institute Of India
India  /  Published 21.09.21

Covishield: 22cr doses in October

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming the export of surplus ...
By Our Bureau, PTI in Pune

India  /  Published 26.08.21

Covishield: 20cr doses in Sept

Serum Institute of India (SII) has informed the Centre that it will be able to supply around 20 crore doses of Covid-19 vaccine Covishield in September itself to Government to India and private hospit...
By Our Bureau, PTI in Pune

India  /  Published 13.08.21

Serum chief praises PM Modi

Recalling how the industry used to face "hardships" in securing permissions and "harassment from bureaucrats" 50 years ago, chairman of the city-based vaccine maker Serum Institute...
By Our Bureau, PTI in Pune

India  /  Published 13.08.21

Serum chief against jab cocktail

Serum Institute of India (SII) chairman Dr Cyrus Poonawalla on Friday said he was not in favour of administering two different coronavirus vaccines for better efficacy. Poonawalla, whose firm makes t...
By Our Bureau, PTI in Pune

India  /  Published 06.08.21

Covovax for adults in Oct: Serum CEO

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and ...
By Jatin Takkar in New Delhi

Advertisement

India  /  Published 21.07.21

Serum Institute asks for drug regulatory reforms

World's largest vaccine manufacturer by volume, Serum Institute of India (SII) has written to Union Health Minister Mansukh Mandaviya suggesting reforms in the existing drug regulatory system, inc...
By Our Bureau, PTI in New Delhi

India  /  Published 14.07.21

Serum signs pact to produce Sputnik V

...
By G.S. Mudur in New Delhi

India  /  Published 13.07.21

SII: Sputnik shots from September

Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday. As per the agreement betwe...
By Our Bureau, PTI in New Delhi

India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi

India  /  Published 30.06.21

Poonawalla: EU nod in a month

Vaccine major Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its Covid-19 vaccine Covishield in a month, company's chief executive officer...
By Our Bureau, PTI in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.